Trial Information

Summary: A study to evaluate the efficacy and safety of an orodispersible (ODT) tablet of vardenafil compared to placebo in men with Erectile Dysfunction (ED).

The purpose of the study is to find out if the study drug orodispersible (ODT) tablet of vardenafil 10 mg will be effective and safe compared to placebo (look-a-like pill with no active medication) for the treatment of erectile dysfunction, also known as ED or impotence.
Compensation Provided

Patient Inclusion/Exclusion Criteria:

-Males 18 years-of-age or older.
-Stable, heterosexual relationship for at least 6 months.
-A history of erectile dysfunction (ED) for at least 6 months.

-Any underlying cardiovascular condition, including unstable angina pectoris (chest pain).
-History of myocardial infarction (heart attack), stroke or life-threatening arrhythmia (abnormal heart beat)within 6 months prior to Visit 1.
-History fo sur

Contact:

Lourdes Campos-Grundvig, RN, MS
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: (212) 241-3141
Fax: (212) 876-3246
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 21, 2008 at 3:39:21 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA